Volcano Corporation (VOLC) - NASDAQ
  • Dec. 17, 2014, 2:32 AM
    • Expanding into the image-guided therapy market, Philips (NYSE:PHG) will acquire Volcano (NASDAQ:VOLC) for $18 per share, a 57% premium to Volcano's closing price on Tuesday.
    • The $1.2B deal is expected to add to Philips' EPS by 2017.
    • VOLC +55.4% premarket
    | Dec. 17, 2014, 2:32 AM
  • May 27, 2014, 4:35 PM
    • Volcano (VOLC +0.9%) acquires privately-held AtheroMed, the developer of the Phoenix Atherectomy System used to treat peripheral artery disease. The Phoenix System received 510(k) clearance in January 2014 and CE Mark in 2013.
    • Under the terms of the acquisition agreement, Volcano will pay $115M at closing and another $15M if the AtheroMed device currently under FDA review receives clearance by November 15, 2014 (design for manufacturing improvements of current device). It will also be eligible for sales-based milestone payments.
    • The global atherectomy market is $350 - 400M growing at 7% per annum.
    | May 27, 2014, 4:35 PM
Company Description
Volcano Corp design, develop, manufacture and commercialize a suite of precision guided therapy tools including intravascular ultrasound, or IVUS, and fractional flow reserve, or FFR, products.
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States